Langsung ke konten

Perawatan Intensif dan Kritis

Penanganan Anemia

Pharmacokinetics and pharmacodynamics of six epoetin alfa dosing regimens in anemic critically ill patients without acute blood loss. (terbuka di window baru)

Arroliga AC, Guntupalli KK, Beaver JS, Langholff W, Marino K, Kelly K

Sumber‎: Crit Care Med 2009;37(4):1299-307.

Index‎: PubMed 19242343

DOI‎: 10.1097/CCM.0b013e31819cec94

https://www.ncbi.nlm.nih.gov/pubmed/19242343 (terbuka di window baru)

Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses. (terbuka di window baru)

Ball AM, Winstead PS.

Sumber‎: Pharmacotherapy 2008;28(11):1383-90.

Index‎: PubMed 18956998

DOI‎: 10.1592/phco.28.11.1383

https://www.ncbi.nlm.nih.gov/pubmed/18956998 (terbuka di window baru)

Reducing postburn injury anemia in a Jehovah's Witness patient. (terbuka di window baru)

Barsun A, Sen S, Palmieri TL, Greenhalgh DG

Sumber‎: J Burn Care Res 2014;35(4):e258-61.

Index‎: PubMed 24121804

DOI‎: 10.1097/BCR.0b013e3182a366c5

https://www.ncbi.nlm.nih.gov/pubmed/24121804 (terbuka di window baru)

A US multicenter, retrospective, observational study of erythropoiesis-stimulating agent utilization in anemic, critically ill patients admitted to the intensive care unit. (terbuka di window baru)

Brophy GM, Sheehan V, Shapiro MJ, Lottenberg L, Scarlata D, Audhya P; ASSESS Study Group and Amgen Inc

Sumber‎: Clin Ther 2008;30(12):2324-34.

Index‎: PubMed 19167591

DOI‎: 10.1016/j.clinthera.2008.12.024

https://www.ncbi.nlm.nih.gov/pubmed/19167591 (terbuka di window baru)

Severe acute anemia after liver transplantation in an elderly Jehovah's Witness treated with high-dose erythropoietin and ferric carboxymaltose: a case report. (terbuka di window baru)

Brunetta DM, Kaufman J, De Santis GC, Mesquita DF, Souza FN, Garcia JH.

Sumber‎: Transplant Proc 2015;47(8):2548-51.

Index‎: PubMed 26518969

DOI‎: 10.1016/j.transproceed.2015.09.014

https://www.ncbi.nlm.nih.gov/pubmed/26518969 (terbuka di window baru)

Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial. (terbuka di window baru)

Corwin HL, Gettinger A, Rodriguez RM, Pearl RG, Gubler KD, Enny C, Colton T, Corwin MJ.

Sumber‎: Crit Care Med 1999;27(11):2346-50.

Index‎: PubMed 10579246

https://www.ncbi.nlm.nih.gov/pubmed/10579246 (terbuka di window baru)

Erythropoietin for critically ill trauma patients: a missed opportunity? (terbuka di window baru)

Corwin HL, Napolitano LM

Sumber‎: J Trauma Acute Care Surg 2014;77(5):774-9.

Index‎: PubMed 25494432

DOI‎: 10.1097/TA.0000000000000442

https://www.ncbi.nlm.nih.gov/pubmed/25494432 (terbuka di window baru)

Postoperative management of severe acute anemia in a Jehovah's Witness. (terbuka di window baru)

de Araújo Azi LM, Lopes FM, Garcia LV

Sumber‎: Transfusion 2014;54(4):1153-7.

Index‎: PubMed 24117834

DOI‎: 10.1111/trf.12424

https://www.ncbi.nlm.nih.gov/pubmed/24117834 (terbuka di window baru)

Restrictive transfusion in geriatric trauma patients. (terbuka di window baru)

DeLeon AN, Uecker JM, Stafford SV, Ali S, Clark A, Brown CV

Sumber‎: Am Surg 2016;82(1):85-8.

Index‎: PubMed 26802863

https://www.ncbi.nlm.nih.gov/pubmed/26802863 (terbuka di window baru)

High-dose recombinant human erythropoietin stimulates reticulocyte production in patients with multiple organ dysfunction syndrome. (terbuka di window baru)

Gabriel A, Kozek S, Chiari A, Fitzgerald R, Grabner C, Geissler K, Zimpfer M, Stockenhuber F, Bircher NG

Sumber‎: J Trauma 1998;44(2):361-7.

Index‎: PubMed 9498512

DOI‎: 10.1097/00005373-199802000-00023

https://www.ncbi.nlm.nih.gov/pubmed/9498512 (terbuka di window baru)

Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317]. (terbuka di window baru)

Georgopoulos D, Matamis D, Routsi C, Michalopoulos A, Maggina N, Dimopoulos G, Zakynthinos E, Nakos G, Thomopoulos G, Mandragos K, Maniatis A; Critical Care Clinical Trials Greek Group.

Sumber‎: Crit Care 2005;9(5):R508-15.

Index‎: PubMed 16277712

DOI‎: 10.1186/cc3786

https://www.ncbi.nlm.nih.gov/pubmed/16277712 (terbuka di window baru)

Long-term ECMO treatment in Jehovah's Witness patient without transfusions. (terbuka di window baru)

Lindholm J, Palmér K, Frenckner B.

Sumber‎: Perfusion 2012;27(4):332-4.

Index‎: PubMed 22496111

DOI‎: 10.1177/0267659112444328

https://www.ncbi.nlm.nih.gov/pubmed/22496111 (terbuka di window baru)

Outcomes with the use of recombinant human erythropoietin in critically ill burn patients. (terbuka di window baru)

Lundy JB, Hetz K, Chung KK, Renz EM, White CE, King BT, Huzar T, Wolf SE, Blackbourne LH

Sumber‎: Am Surg 2010;76(9):951-6.

Index‎: PubMed 20836341

https://www.ncbi.nlm.nih.gov/pubmed/20836341 (terbuka di window baru)

Safety of off-label erythropoiesis stimulating agents in critically ill patients: a meta-analysis. (terbuka di window baru)

Mesgarpour B, Heidinger BH, Schwameis M, Kienbacher C, Walsh C, Schmitz S, Herkner H.

Sumber‎: Intensive Care Med 2013;39(11):1896-908.

Index‎: PubMed 23928897

DOI‎: 10.1007/s00134-013-3030-9

https://www.ncbi.nlm.nih.gov/pubmed/23928897 (terbuka di window baru)

Transfusion-free treatment strategies for acute anemia in critical care. (terbuka di window baru)

Morgan CA, Byul Sarah S, Forest CP.

Sumber‎: JAAPA 2016;29(8):38-44.

Index‎: PubMed 27467297

DOI‎: 10.1097/01.JAA.0000488695.96294.33

https://www.ncbi.nlm.nih.gov/pubmed/27467297 (terbuka di window baru)

Improved survival of critically ill trauma patients treated with recombinant human erythropoietin. (terbuka di window baru)

Napolitano LM, Fabian TC, Kelly KM, Bailey JA, Block EF, Langholff W, Enny C, Corwin HL.

Sumber‎: J Trauma 2008;65(2):285-97.

Index‎: PubMed 18695463

DOI‎: 10.1097/TA.0b013e31817f2c6e

https://www.ncbi.nlm.nih.gov/pubmed/18695463 (terbuka di window baru)

Reticulocyte counts and their relation to hemoglobin levels in trauma patients. (terbuka di window baru)

Otterman ML, Nijboer JM, van der Horst IC, van Meurs M, ten Duis HJ, Nijsten MW

Sumber‎: J Trauma 2009;67(1):121-4.

Index‎: PubMed 19590320

DOI‎: 10.1097/TA.0b013e318187a848

https://www.ncbi.nlm.nih.gov/pubmed/19590320 (terbuka di window baru)

Randomized, double-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness. (terbuka di window baru)

Pieracci FM, Henderson P, Rodney JR, Holena DN, Genisca A, Ip I, Benkert S, Hydo LJ, Eachempati SR, Shou J, Barie PS.

Sumber‎: Surg Infect (Larchmt) 2009;10(1):9-19.

Index‎: PubMed 19245362

DOI‎: 10.1089/sur.2008.043

https://www.ncbi.nlm.nih.gov/pubmed/19245362 (terbuka di window baru)

How do we treat life-threatening anemia in a Jehovah's Witness patient? (terbuka di window baru)

Posluszny JA Jr, Napolitano LM.

Sumber‎: Transfusion 2014;54(12):3026-34.

Index‎: PubMed 25330835

DOI‎: 10.1111/trf.12888

https://www.ncbi.nlm.nih.gov/pubmed/25330835 (terbuka di window baru)

Recombinant human erythropoietin use in a critically ill Jehovah's Witness after cardiac surgery. (terbuka di window baru)

Price S, Pepper JR, Jaggar SI.

Sumber‎: Anesth Analg 2005;101(2):325-7.

Index‎: PubMed 16037136

DOI‎: 10.1213/01.ANE.0000159158.70532.D0

https://www.ncbi.nlm.nih.gov/pubmed/16037136 (terbuka di window baru)

Erythropoietin response is blunted in critically ill patients. (terbuka di window baru)

Rogiers P, Zhang H, Leeman M, Nagler J, Neels H, Mélot C, Vincent JL

Sumber‎: Intensive Care Med 1997;23(2):159-62.

Index‎: PubMed 9069000

DOI‎: 10.1007/s001340050310

https://www.ncbi.nlm.nih.gov/pubmed/9069000 (terbuka di window baru)

Life-threatening postoperative blood loss in a Jehovah's Witness, treated with high-dose erythropoietin. (terbuka di window baru)

Schälte G, Janz H, Busse J, Jovanovic V, Rossaint R, Kuhlen R.

Sumber‎: Br J Anaesth 2005;94(4):442-4.

Index‎: PubMed 15653706

DOI‎: 10.1093/bja/aei068

https://www.ncbi.nlm.nih.gov/pubmed/15653706 (terbuka di window baru)

Management of anemia in patients who decline blood transfusion. (terbuka di window baru)

Shander A, Goodnough LT

Sumber‎: Am J Hematol 2018;93(9):1183-91.

Index‎: PubMed 30033541

DOI‎: 10.1002/ajh.25167

https://pubmed.ncbi.nlm.nih.gov/30033541/ (terbuka di window baru)

Erythropoiesis-stimulating agent administration and survival after severe traumatic brain injury: a prospective study. (terbuka di window baru)

Talving P, Lustenberger T, Inaba K, Lam L, Mohseni S, Chan L, Demetriades D.

Sumber‎: Arch Surg 2012;147(3):251-5.

Index‎: PubMed 22430906

DOI‎: 10.1001/archsurg.2011.1838

https://www.ncbi.nlm.nih.gov/pubmed/22430906 (terbuka di window baru)

Intravenous iron following cardiac surgery does not increase the infection rate. (terbuka di window baru)

Torres S, Kuo YH, Morris K, Neibart R, Holtz JB, Davis JM.

Sumber‎: Surg Infect (Larchmt) 2006;7(4):361-6.

Index‎: PubMed 16978079

DOI‎: 10.1089/sur.2006.7.361

https://www.ncbi.nlm.nih.gov/pubmed/16978079 (terbuka di window baru)

Erythropoietin improves long-term neurological outcome in acute ischemic stroke patients: a randomized, prospective, placebo-controlled clinical trial. (terbuka di window baru)

Tsai TH, Lu CH, Wallace CG, Chang WN, Chen SF, Huang CR, Tsai NW, Lan MY, Sung PH, Liu CF, Yip HK

Sumber‎: Crit Care 2015;19:49.

Index‎: PubMed 25888250

DOI‎: 10.1186/s13054-015-0761-8

https://www.ncbi.nlm.nih.gov/pubmed/25888250 (terbuka di window baru)

Pharmacotherapy for reducing RBC transfusion for patients in the ICU: a systematic review and network meta-analysis. (terbuka di window baru)

Yoshihiro S, Hongo T, Yamamoto M, Taito S, Kataoka Y

Sumber‎: Crit Care Med 2024;52(4):618-25.

Index‎: PubMed 37962159

DOI‎: 10.1097/CCM.0000000000006114

https://pubmed.ncbi.nlm.nih.gov/37962159/ (terbuka di window baru)